Literature DB >> 11920862

Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism.

Maria Cristina Cavallini1, Daniela Di Bella, Francesca Siliprandi, Francesca Malchiodi, Laura Bellodi.   

Abstract

The determination of a genetic basis for obsessive-compulsive disorder (OCD) depends on how phenotypic boundaries are defined. Although a hypothesis for serotonin dysfunction in OCD has been advanced, no genes specifically responsible for serotonin regulation have as yet been definitively related to the etiology of OCD. The phenotypic variability of OCD could be at the basis of the failure of molecular biology investigations to find any genes involved in the liability to the disorder. Obsessive and compulsive contents can aggregate in OCD patients differently; multifactorial description may therefore be able to account for OCD phenotypic variance. Using principal component analysis, we derived five factors from 13 main contents of the Yale-Brown Obsessive-Compulsive Scale (YBOCS), and considered them as quantitative phenotypes to evaluate their possible association with an insertion/deletion polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR). A trend toward positive association between the fifth factor, including counting and repeating rituals, and 5-HTTLPR was found. However, only considering the subgroup of patients with tic codiagnosis, we found a significantly higher score for the fifth factor for patients with L/L genotype with respect to L/S and S/S genotypes. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920862     DOI: 10.1002/ajmg.1700

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  22 in total

1.  Paroxetine treatment of compulsive hoarding.

Authors:  Sanjaya Saxena; Arthur L Brody; Karron M Maidment; Lewis R Baxter
Journal:  J Psychiatr Res       Date:  2006-06-21       Impact factor: 4.791

Review 2.  Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.

Authors:  David L Pauls; Amitai Abramovitch; Scott L Rauch; Daniel A Geller
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

Review 3.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

Review 4.  Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment.

Authors:  N A Fineberg; S R Chamberlain; E Hollander; V Boulougouris; T W Robbins
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Toward understanding the heterogeneity in obsessive-compulsive disorder: Evidence from narratives in adult patients.

Authors:  Gerrit I Van Schalkwyk; Ish P Bhalla; Matthew Griepp; Benjamin Kelmendi; Larry Davidson; Christopher Pittenger
Journal:  Aust N Z J Psychiatry       Date:  2015-04-08       Impact factor: 5.744

6.  Symptom dimensions in OCD: item-level factor analysis and heritability estimates.

Authors:  Hilga Katerberg; Kevin L Delucchi; S Evelyn Stewart; Christine Lochner; Damiaan A J P Denys; Denise E Stack; J Michael Andresen; J E Grant; Suck W Kim; Kyle A Williams; Johan A den Boer; Anton J L M van Balkom; Johannes H Smit; Patricia van Oppen; Annemiek Polman; Michael A Jenike; Dan J Stein; Carol A Mathews; Danielle C Cath
Journal:  Behav Genet       Date:  2010-04-02       Impact factor: 2.805

Review 7.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

Review 8.  Genetic and environmental influences on obsessive-compulsive disorder.

Authors:  Jessica R Grisham; Tracy M Anderson; Perminder S Sachdev
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

9.  Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.

Authors:  Angeli Landeros-Weisenberger; Michael H Bloch; Ben Kelmendi; Ryan Wegner; Jake Nudel; Philip Dombrowski; Christopher Pittenger; John H Krystal; Wayne K Goodman; James F Leckman; Vladimir Coric
Journal:  J Affect Disord       Date:  2009-07-03       Impact factor: 4.839

10.  Psychometric properties of the DY-BOCS in a Turkish sample of children and adolescents.

Authors:  Ayşegül Selcen Güler; Maria Conceição do Rosário; Ayşe Burcu Ayaz; Sebla Gökçe; Yasemin Yulaf; Senem Başgül; Özlem Özcan; Koray Karabekiroğlu; Kerim Munir; Lütfullah Beşiroğlu; Yankı Yazgan
Journal:  Compr Psychiatry       Date:  2015-09-24       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.